China Automakers Accelerate Global Expansion as Domestic Car Sales Slump 
Asian Currencies Steady as Dollar Holds Firm After U.S. Inflation Data 
Asian Stocks Rally as Cooling US Inflation Boosts Fed Rate Outlook 
Australia’s Corporate Leaders Face Parliament Over KPMG Client Data Scandal 
Canada, US Hold Fresh Trade Talks as August 19 Tariff Deadline Nears 
OpenAI Executive Brad Lightcap to Leave for New AI Venture 
KOSPI Eyes Best Weekly Gain Since June as Samsung, SK Hynix Rally 
Maersk Raises 2026 Earnings Outlook as Shipping Profits Beat Expectations 
Antofagasta Shares Drop 5% as Miner Cuts 2026 Copper Production Forecast 
SMIC Shares Rally as Q2 Profit Surges 262% on Strong Chip Demand 
Google Pushes Gemini AI Overhaul as Sergey Brin Targets Model Supremacy 
Canada-US Trade Talks Gain Momentum Ahead of Aug. 19 Tariff Deadline 
Gold Prices Slip From 10-Week High as Fed and Hormuz Risks Shape Outlook 
European Stocks Rise as U.S. Inflation Data Eases Fed Rate Hike Fears 
Anthropic Signs $9.1B AI Data Center Deal With Riot Platforms 
Oil, Gold Rise as Geopolitical Risks Grip Markets Ahead of U.S. CPI 
Ford to Move Some Lincoln Production From China to U.S. in 2030 
Add as a preferred source on Google
3M, an American conglomerate operating in industry, worker safety, healthcare, and consumer goods, announced the appointment of Bryan Hanson as chief executive officer of its new healthcare business.
On Tuesday, Aug. 22, it said that the newly-appointed executive will lead the healthcare group that it plans to spinoff. Last year, 3M shared its plans to create a new branch for its healthcare line.
There are plans to turn this health business into a listed company where 3M will keep its 19.9% stake. The firm is looking to complete the spinoff before this year ends. As per Reuters, the plan is to direct the focus of this healthcare unit to oral care, wound care, and healthcare technology, accounting for around 25% of the company's $34.43 billion in sales in 2022.
In any case, Hanson will officially join 3M on Sept. 1 and immediately assume the role of CEO of the firm's Health Care Business Group. Before this appointment, he worked as president and chief at Zimmer Biomet since 2017. He was promoted to the chairman post in 2021, and now he has left the Indiana-based medical equipment manufacturer to move to 3M.
Aside from hiring a new CEO, 3M also revealed that Carrie Cox, the former chairman and CEO of Humacyte Inc., will also be the chairman of the board of directors for the healthcare spinoff.
"We are pleased to have Bryan join us to successfully complete the spinoff of our Health Care business and build a leading independent medical technology innovation company," 3 M's chairman and chief executive officer, Mike Roman, said in a press release. "His industry expertise, ability to drive growth, and track record of building a strong culture and teams will make an immediate impact."
Photo by: visuals/Unsplash
